Chang Lee

Chang Lee is a seasoned regulatory affairs professional with extensive experience in the pharmaceutical industry. They have held various leadership positions, including Regulatory Affairs Group Director at AstraZeneca since 2022 and previously as Regulatory Affairs Project Director from 2016 to 2021. Chang served as Director of Regulatory Affairs at Progenics Pharmaceuticals and Intercell AG, and was also Associate Director at MedImmune. They hold a BA in Biochemistry from Rutgers University, an MBA in General Management from Villanova University, and a MS in QA/RA from Temple University.